Skip to main content

Access to Vaccines and Immunization Programme

  • Chapter
Book cover Global Pharmaceutical Policy
  • 542 Accesses

Abstract

Vaccine, one of the most cost-effective health interventions, is a health prevention tool to protect humans against infectious diseases. Access to vaccine is one of the foci among health policy makers around the globe. To improve the access to vaccine and immunization programme, several health policies have been implemented including WHO Expanded Programme on Immunization (EPI), the establishment of Global Alliance for Vaccines and Immunisation (GAVI) and the Global Vaccine Action Plan 2011–2020. Future challenges include the increase in vaccine hesitancy rate, the use of mandatory immunization and the inclusion of adult and adolescent vaccine into the EPI.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Henderson DA. The eradication of smallpox–an overview of the past, present, and future. Vaccine. 2011;29:D7–D9.

    Article  Google Scholar 

  • World Health Organization. Poliomyelitis Key facts: World Health Organization; 2019a Available from: https://www.who.int/en/news-room/fact-sheets/detail/poliomyelitis.

  • Maurice JM, Davey S. State of the World’s Vaccines and Immunization: World Health Organization; 2009.

    Google Scholar 

  • World Health Organization. Vaccines and diseases: World Health Organization; 2019b Available from: https://www.who.int/immunization/diseases/en/.

  • Angela K. Shen MTC. From the Analyst’s Couch: Infectious disease vaccines: Nature Reviews Drug Discovery; 2018 Available from: https://www.nature.com/articles/d41573-018-00011-6.

  • Keja K, Chan C, Hayden G, Henderson RH. Expanded programme on immunization. World health statistics quarterly Rapport trimestriel de statistiques sanitaires mondiales. 1988;41(2):59–63.

    Google Scholar 

  • Plotkin S, Robinson JM, Cunningham G, Iqbal R, Larsen S. The complexity and cost of vaccine manufacturing–an overview. Vaccine. 2017;35(33):4064–71.

    Article  Google Scholar 

  • Mitchell VS, Philipose NM, Sanford JP. The children’s vaccine initiative: achieving the vision: National Academies Press; 1993.

    Google Scholar 

  • U.S. Food and Drug Administration. Vaccine Product Approval Process: U.S. Food and Drug Administration; 2018 Available from: https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/vaccine-product-approval-process.

  • Vidor E, Soubeyrand B. Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools. Expert review of vaccines. 2016;15(12):1575–82.

    Article  Google Scholar 

  • Cutts FT, Claquin P, Danovaro-Holliday MC, Rhoda DA. Monitoring vaccination coverage: defining the role of surveys. Vaccine. 2016;34(35):4103–9.

    Article  Google Scholar 

  • Utazi CE, Thorley J, Alegana VA, Ferrari MJ, Takahashi S, Metcalf CJE, et al. Mapping vaccination coverage to explore the effects of delivery mechanisms and inform vaccination strategies. Nature communications. 2019;10(1):1633.

    Article  Google Scholar 

  • Mbabazi WB, Nanyunja M, Makumbi I, Braka F, Baliraine FN, Kisakye A, et al. Achieving measles control: lessons from the 2002–06 measles control strategy for Uganda. Health policy and planning. 2009;24(4):261–9.

    Article  Google Scholar 

  • Mane AB. Letter to Editor: Immunization Dropout Rates: Some Issues. Annals of medical and health sciences research. 2015;5(2):153.

    Article  Google Scholar 

  • Sridhar S, Maleq N, Guillermet E, Colombini A, Gessner BD. A systematic literature review of missed opportunities for immunization in low-and middle-income countries. Vaccine. 2014;32(51):6870–9.

    Article  Google Scholar 

  • Kidd S, Ouedraogo B, Kambire C, Kambou JL, McLean H, Kutty PK, et al. Measles outbreak in Burkina Faso, 2009: a case–control study to determine risk factors and estimate vaccine effectiveness. Vaccine. 2012;30(33):5000–8.

    Article  Google Scholar 

  • Murthy N, Rodgers L, Pabst L, Fiebelkorn AP, Ng T. Progress in childhood vaccination data in immunization information systems—United States, 2013–2016. MMWR Morbidity and mortality weekly report. 2017;66(43):1178.

    Article  Google Scholar 

  • Sato AS, Ferreira VDR, Tauil MDC, Costa ÂA, Inenami M, Rodrigues LC, et al. Monitoring vaccination coverage by electronic immunization registry in medium-sized city, Brazil. Revue d’Épidémiologie et de Santé Publique. 2018;66:S422.

    Article  Google Scholar 

  • Nguyen NT, Vu HM, Dao SD, Tran HT, Nguyen TXC. Digital immunization registry: evidence for the impact of mHealth on enhancing the immunization system and improving immunization coverage for children under one year old in Vietnam. Mhealth. 2017;3.

    Google Scholar 

  • Brown DW, Burton AH, Feeney G, Gacic-Dobo M. Avoiding the will o’ the wisp: challenges in measuring high levels of immunization coverage with precision. World Journal of Vaccines. 2014;4(03):97.

    Article  Google Scholar 

  • Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bulletin of the World Health Organization. 2009;87:535–41.

    Article  Google Scholar 

  • Lim SS, Stein DB, Charrow A, Murray CJ. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. The Lancet. 2008;372(9655):2031–46.

    Article  Google Scholar 

  • World Health Organization. Immunization coverage cluster survey: Reference manual. Geneva: World Health Organization; 2005.

    Google Scholar 

  • Danovaro-Holliday MC, Dansereau E, Rhoda DA, Brown DW, Cutts FT, Gacic-Dobo M. Collecting and using reliable vaccination coverage survey estimates: Summary and recommendations from the “Meeting to share lessons learnt from the roll-out of the updated WHO Vaccination Coverage Cluster Survey Reference Manual and to set an operational research agenda around vaccination coverage surveys”, Geneva, 18–21 April 2017. Vaccine. 2018;36(34):5150–9.

    Article  Google Scholar 

  • Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999–2009. Vaccine. 2011;29(46):8215–21.

    Article  Google Scholar 

  • Favin M, Steinglass R, Fields R, Banerjee K, Sawhney M. Why children are not vaccinated: a review of the grey literature. International health. 2012;4(4):229–38.

    Article  Google Scholar 

  • Xeuatvongsa A, Hachiya M, Miyano S, Mizoue T, Kitamura T. Determination of factors affecting the vaccination status of children aged 12–35 months in Lao People’s Democratic Republic. Heliyon. 2017;3(3):e00265.

    Article  Google Scholar 

  • Bryson M, Duclos P, Jolly A, Bryson J. A systematic review of national immunization policy making processes. Vaccine. 2010;28:A6–A12.

    Article  Google Scholar 

  • World Health Organization. Global Vaccine Action Plan 2011–2020: World Health Organization; 2019c Available from: https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/.

  • NITAG Resource Center. National Immunization Technical Advisory Groups (NITAGs) Worldwide: NITAG Resource Center; 2019 Available from: http://www.nitag-resource.org/.

  • Shen AK, Fields R, McQuestion M. The future of routine immunization in the developing world: challenges and opportunities. Global Health: Science and Practice. 2014;2(4):381–94.

    Google Scholar 

  • Okwo-Bele J-M, Cherian T. The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine. 2011;29:D74–D9.

    Article  Google Scholar 

  • K V Balasubramaniam VS. Access to Vaccines and the Vaccine Industry - An Analysis. Journal of Vaccines & Vaccination. 2014;5(2).

    Google Scholar 

  • Makenga G, Bonoli S, Montomoli E, Carrier T, Auerbach J. Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction. Frontiers in public health. 2019;7:56.

    Article  Google Scholar 

  • Storeng KT. The GAVI Alliance and the ‘Gates approach’ to health system strengthening. Global public health. 2014;9(8):865–79.

    Article  Google Scholar 

  • Gavi tVA. Gavi Annual Progress Report 2017: Gavi, the Vaccine Alliance; 2017 Available from: http://gaviprogressreport.org/2017/.

  • VanderEnde K, Gacic-Dobo M, Diallo MS, Conklin LM, Wallace AS. Global Routine Vaccination Coverage – 2017. MMWR Morb Mortal Wkly Rep. 2018;67(45):1261–4.

    Article  Google Scholar 

  • Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K. Measles outbreak—California, December 2014–February 2015. MMWR Morbidity and mortality weekly report. 2015;64(6):153.

    Google Scholar 

  • Woudenberg T, van Binnendijk RS, Sanders EA, Wallinga J, de Melker HE, Ruijs WL, et al. Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology. Eurosurveillance. 2017;22(3).

    Google Scholar 

  • Strategic Advisory Group of Experts (SAGE) on Immunization. Report of the SAGE Working Group on Vaccine Hesitancy World Health Organization; 2014 Available from: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf.

  • Dubé E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert review of vaccines. 2015a;14(1):99–117.

    Article  Google Scholar 

  • Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, et al. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165–75.

    Article  Google Scholar 

  • Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: causes, consequences, and a call to action. Vaccine. 2015;33:D66–D71.

    Article  Google Scholar 

  • François G, Duclos P, Margolis H, Lavanchy D, Siegrist C-A, Meheus A, et al. Vaccine safety controversies and the future of vaccination programs. The Pediatric infectious disease journal. 2005;24(11):953–61.

    Article  Google Scholar 

  • Poland GA, Spier R. Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health. Vaccine. 2010;28(12):2361.

    Article  Google Scholar 

  • Smith LE, Amlôt R, Weinman J, Yiend J, Rubin GJ. A systematic review of factors affecting vaccine uptake in young children. Vaccine. 2017;35(45):6059–69.

    Article  Google Scholar 

  • Dubé E, Gagnon D, MacDonald NE. Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccine. 2015b;33(34):4191–203.

    Article  Google Scholar 

  • Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014;133(4):e835–e42.

    Article  Google Scholar 

  • Bozzola E, Spina G, Russo R, Bozzola M, Corsello G, Villani A. Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. Italian journal of pediatrics. 2018;44(1):67.

    Article  Google Scholar 

  • MacDonald NE, Harmon S, Dube E, Steenbeek A, Crowcroft N, Opel DJ, et al. Mandatory infant & childhood immunization: Rationales, issues and knowledge gaps. Vaccine. 2018.

    Google Scholar 

  • Lee C, Robinson JL. Systematic review of the effect of immunization mandates on uptake of routine childhood immunizations. Journal of Infection. 2016;72(6):659–66.

    Article  Google Scholar 

  • Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, et al. Preventing tetanus, diphtheria, and pertussis among adolescents; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2006.

    Google Scholar 

  • Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older—United States, 2017. MMWR Morbidity and mortality weekly report. 2017;66(5):136.

    Article  Google Scholar 

  • Williams WW, Lu P-J, O’Halloran A, Bridges CB, Kim DK, Pilishvili T, et al. Vaccination coverage among adults, excluding influenza vaccination—United States, 2013. MMWR Morbidity and mortality weekly report. 2015;64(4):95.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suthira Taychakhoonavudh .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Author(s)

About this chapter

Cite this chapter

Taychakhoonavudh, S. (2020). Access to Vaccines and Immunization Programme. In: Babar, ZUD. (eds) Global Pharmaceutical Policy. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-15-2724-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-2724-1_12

  • Publisher Name: Palgrave Macmillan, Singapore

  • Print ISBN: 978-981-15-2723-4

  • Online ISBN: 978-981-15-2724-1

  • eBook Packages: Social SciencesSocial Sciences (R0)

Publish with us

Policies and ethics